Stockscreener 앱 받기
6.25
3.31%
0.20
Diamedica Therapeutics Inc 주식(DMAC)의 최신 뉴스
MSN Money - MSN
DiaMedica Therapeutics Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The National Law Review
DiaMedica Therapeutics (DMAC) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026 - BioSpace
Top Wall Street forecasters revamp DiaMedica Therapeutics expectations ahead of Q4 earnings - MSN
DMAC Price Today: DiaMedica Therapeutics Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
DMAC DiaMedica Therapeutics Inc. reports narrower Q4 2025 loss than consensus forecasts, its stock rises modestly in today’s trading.Expert Market Insights - Cổng thông tin điện tử tỉnh Tây Ninh
Is DiaMedica (DMAC) stock worth committing funds to (Drifts Higher) 2026-04-22Community Risk Signals - Cổng thông tin điện tử tỉnh Lào Cai
DiaMedica Therapeutics Highlights DM199 Preeclampsia Data, Stroke Interim Catalyst at RedChip Conference - MarketBeat
EBITDA per share of DiaMedica Therapeutics Inc. – NASDAQ:DMAC - TradingView
Is DiaMedica Therapeutics Inc a cyclical or defensive stock2026 Market Sentiment & Precise Swing Trade Alerts - baoquankhu1.vn
Returns Recap: How does DiaMedica Therapeutics Inc compare to its peers2026 Geopolitical Influence & Technical Entry and Exit Tips - baoquankhu1.vn
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms - marketscreener.com
Should I Buy DiaMedica (DMAC) Stock Today | Price at $6.62, Up 2.16%Community Watchlist - Newser
Q1 EPS Estimate for DiaMedica Therapeutics Raised by Analyst - MarketBeat
What is HC Wainwright’s Forecast for DMAC FY2029 Earnings? - Defense World
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Diamedica Therapeutics (DMAC), Elevance Health (ELV) and Oric Pharmaceuticals (ORIC) - The Globe and Mail
HC Wainwright Issues Pessimistic Estimate for DMAC Earnings - MarketBeat
[ARS] DiaMedica Therapeutics Inc. SEC Filing - Stock Titan
Equity plan expansion at DiaMedica (NASDAQ: DMAC) adds 3.5M shares - Stock Titan
H.C. Wainwright reiterates DiaMedica stock rating on trial progress By Investing.com - Investing.com India
H.C. Wainwright reiterates DiaMedica stock rating on trial progress - Investing.com
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2025 Earnings Call Transcript - Insider Monkey
DiaMedica Therapeutics Furnishes 2025 Financial Results and Business Update - The Globe and Mail
DMAC Should I Buy - Intellectia AI
DiaMedica Therapeutics Inc (DMAC) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... By GuruFocus - Investing.com Canada
DiaMedica Therapeutics Inc.Common Stock - FinancialContent
DiaMedica Therapeutics Reports 2025 Financial Results - National Today
DiaMedica reiterates plan for ReMEDy2 interim analysis in 2H 2026 as stroke trial approaches 70% of 200 patients - MSN
DiaMedica Therapeutics Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
DiaMedica Therapeutics Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: DiaMedica Therapeutics Q4 2025 shows liquidity boost - Investing.com Canada
Earnings call transcript: DiaMedica Therapeutics Q4 2025 shows liquidity boost By Investing.com - Investing.com South Africa
DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights - BioSpace
Loss Report: Is DiaMedica Therapeutics Inc a cyclical or defensive stockTrade Analysis Report & AI Optimized Trading Strategy Guides - baoquankhu1.vn
DiaMedica Therapeutics (DMAC) Strengthens Financial Position and Advances Clinical Programs - GuruFocus
Rising R&D widens loss as DiaMedica (NASDAQ: DMAC) funds DM199 - Stock Titan
DiaMedica Therapeutics (NASDAQ:DMAC) Issues Quarterly Earnings Results, Meets Expectations - MarketBeat
DiaMedica Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
0.14%
0.48%
자본화:
|
볼륨(24시간):